Day: August 13, 2021

Atlanticus Reports Second Quarter 2021 Financial Results

Atlanticus Reports Second Quarter 2021 Financial Results

Net Income Attributable to Common Shareholders Increases 74.4% to $32.1 Million, or $2.12 Per Share ATLANTA, Aug. 13, 2021 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a technology-enabled financial services company that assists financial institutions in offering credit to millions of everyday Americans, today announced its financial results for its second quarter ended June 30, 2021. Financial and Operating Highlights 2021 Second Quarter compared to 2020 Second Quarter Net income attributable to common shareholders increased 74.4% to $32.1 million compared to $18.4 million for the second quarter of 2020. This reflects: $2.12 per basic common share, compared to $1.28 per basic common share, an increase of 65.6%; and $1.56 per diluted common share compared...

Continue reading

D-BOX Announces Management Cease Trade Order Per National Policy 12-203

D-BOX Announces Management Cease Trade Order Per National Policy 12-203

MONTREAL, Aug. 13, 2021 (GLOBE NEWSWIRE) — D-BOX Technologies Inc. (“D-BOX” or the “Corporation”) (TSX: DBO) announces that further to its news release dated July 28, 2021 (the “Default Announcement”) relating to the gradual resumption of its activities following a ransomware cyberattack and an anticipated delay in the filing of its unaudited and condensed interim consolidated financial statements, its management’s discussion and analysis for the quarter ended June 30, 2021 and related Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) certifications which were due on August 14, 2021 (collectively the “Required Documents”), the Corporation’s principal regulator, the Autorité des marchés financiers (the “AMF”) granted a management cease trade order (the “MCTO”) on August 12, 2021, under National Policy...

Continue reading

Kelso Technologies Inc. Financial Results for the Six Months Ended June 30, 2021

Kelso Technologies Inc. Financial Results for the Six Months Ended June 30, 2021

VANCOUVER, British Columbia and BONHAM, Texas, Aug. 13, 2021 (GLOBE NEWSWIRE) — Kelso Technologies Inc. (“Kelso” or the “Company”), (TSX: KLS), (NYSE American: KIQ) reports that the Company has released the unaudited consolidated interim financial statements and Management Discussion and Analysis for the six months ended June 30, 2021. The unaudited consolidated interim financial statements were prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). All amounts herein are expressed in United States dollars (the Company’s functional currency) unless otherwise indicated. SUMMARY OF FINANCIAL PERFORMANCE Six months ended June 30   2021     2020   Revenues $ 3,335,838   $ 8,167,966   Gross profit $ 1,402,807   $ 3,698,006   Gross profit...

Continue reading

The Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin Pharmaceuticals

The Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin Pharmaceuticals

Special General Meeting of Shareholders Scheduled for September 19, 2021 Tel Aviv, Israel, Aug. 13, 2021 (GLOBE NEWSWIRE) — Cellect Biotechnology Ltd. (NASDAQ: “APOP”), a developer of innovative technology that enables the functional selection of stem cells, announced that its registration statement filed on Form F-4 with Securities and Exchange Commission (“SEC”) on August 10, 2021 was declared effective by the SEC on August 12, 2021 (the “Form F-4”). The Form F-4 was filed in connection with the previously announced strategic merger with Quoin Pharmaceuticals, Inc., a privately held U.S. based company focused on rare and orphan diseases. The Company has scheduled a Special General Meeting of Shareholders for September 19, 2021, and anticipates closing the transaction by September 30, 2021, subject to completion of...

Continue reading

10X Capital Venture Acquisition Corp. II Announces Closing of $200 Million Initial Public Offering

10X Capital Venture Acquisition Corp. II Announces Closing of $200 Million Initial Public Offering

New York, NY , Aug. 13, 2021 (GLOBE NEWSWIRE) — 10X Capital Venture Acquisition Corp. II (Nasdaq: VCXAU) (the “Company”) today announced that it closed its initial public offering of 20,000,000 units. The offering was priced at $10.00 per unit, resulting in gross proceeds of $200,000,000. The units are listed on the Nasdaq Stock Market (“Nasdaq”) and commenced trading under the ticker symbol “VXCAU” on August 11, 2021. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “VCXA” and “VCXAW,”...

Continue reading

Casella Waste Systems Announces Chief Accounting Officer Retirement

Casella Waste Systems Announces Chief Accounting Officer Retirement

RUTLAND, Vt., Aug. 13, 2021 (GLOBE NEWSWIRE) — Casella Waste Systems, Inc. (“Casella”) (Nasdaq: CWST), a regional solid waste, recycling and resource management services company, announced that the Company’s Vice President and Chief Accounting Officer, Christopher B. Heald plans to retire on March 31, 2022 after a 20-year career with the company. “I would like to sincerely thank Chris for his exemplary service to the company and his strong contributions to our success throughout his tenure with the company,” said John W. Casella, Chairman and CEO of Casella. “Chris has demonstrated the utmost integrity, a strong work ethic, and a high level of service to our team throughout his exemplary career at the company. Through his steady leadership, he has helped to build the accounting and shared services teams and functions. While Chris...

Continue reading

Lifetime Brands to Present at Sidoti Virtual Microcap Conference on August 18, 2021

Lifetime Brands to Present at Sidoti Virtual Microcap Conference on August 18, 2021

GARDEN CITY, N.Y., Aug. 13, 2021 (GLOBE NEWSWIRE) — Lifetime Brands, Inc. (NasdaqGS: LCUT), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, will present at the Sidoti Virtual Microcap Conference on Wednesday, August 18, 2021. Lifetime Brands Chief Executive Officer Robert Kay and Chief Financial Officer Laurence Winoker will present at 11:30 AM ET. The Company’s presentation and a recording of the event can be accessed by clicking on the following link: https://sidoti.cventevents.com/c/calendar/5be7c6b9-8c4d-4a45-bb2e-f585a0ba031d. Lifetime Brands, Inc.Lifetime Brands is a leading global designer, developer and marketer of a broad range of branded consumer products used in the home. The Company markets its products under well-known kitchenware brands, including Farberware®,...

Continue reading

New Verisk and Matterport Integration Accelerates Sketching Process for Insurance Claims

New Verisk and Matterport Integration Accelerates Sketching Process for Insurance Claims

Matterport TruePlan for Xactimate accelerates insurance claims by generating 3-D sketches in one click and streamlining a formerly manual process LEHI, Utah and SUNNYVALE, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) — Property professionals can now rapidly generate digital 3D diagrams of loss sites directly in Verisk’s Xactimate® solution with Matterport TruePlan™ for Xactimate, a new integration with Matterport, Inc. (Nasdaq: MTTR), the leading spatial data company driving the digital transformation of the built world. Xactimate is a powerful claims-estimating solution developed by Verisk’s Xactware business. Verisk (Nasdaq: VRSK) is a leading global provider of predictive analytics and decision-support solutions. Matterport TruePlan for Xactimate converts 3D models into editable digital diagrams, eliminating the need for property...

Continue reading

Vera Bradley Foundation for Breast Cancer  Announces Updates to September Classic Events Schedule

Vera Bradley Foundation for Breast Cancer Announces Updates to September Classic Events Schedule

FORT WAYNE, Ind., Aug. 13, 2021 (GLOBE NEWSWIRE) — The Vera Bradley Foundation for Breast Cancer (the “Foundation”) today announced scheduling updates for its upcoming signature fundraiser, the Vera Bradley Foundation for Breast Cancer Classic (the “Classic), planned for September 17 – September 20, 2021 in Fort Wayne, Indiana. The following modifications to the event schedule have been made to ensure the health and safety of all participants, sponsors, volunteers and other attendees in light of the recent rise of COVID-19 cases throughout the United States and in the Fort Wayne community: The Classic’s Mixed Doubles and Women’s Doubles Pink Pickleball Tournament on September 17 and September 18, as well as the 9-Hole and 18-Hole Women’s Golf Tournaments on September 20, will proceed as planned. However, enhanced safety...

Continue reading

Employee Elected Director to step down from the board of Zealand Pharma A/S

Employee Elected Director to step down from the board of Zealand Pharma A/S

Company announcement No. 51 / 2021 Employee Elected Director to step down from the board of Zealand Pharma A/S Copenhagen, DK, August 13, 2021 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20045078). Gertrude Koefoed Rasmussen an employee elected member of the Board of Zealand will step down from her position on the board effective as of 31 August 2021 and leave Zealand to take up an offer of employment at another company. # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) is a biotechnology company focused on the discovery, development and commercialization of next generation peptide-based medicines that change the lives of people living with metabolic and gastrointestinal diseases. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.